One-year Results of Aflibercept Treatment for Polypoidal Choroidal Vasculopathy with Good Visual Acuity

PURPOSE: To evaluate the one-year efficacy of intravitreal aflibercept injection in polypoidal choroidal vasculopathy (PCV) with best-corrected visual acuity (BCVA) of 20 / 40 or better. METHODS: This was a multicenter retrospective study. The medical records of patients diagnosed with treatment-naï...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Ji Min, Pak, Kang Yeun, Lee, Jae Jung, Sagong, Min, Kim, Hyun Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Ophthalmological Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904418/
https://www.ncbi.nlm.nih.gov/pubmed/33307629
http://dx.doi.org/10.3341/kjo.2020.0096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904418/
https://www.ncbi.nlm.nih.gov/pubmed/33307629
http://dx.doi.org/10.3341/kjo.2020.0096

Ejemplares similares